Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (241-250 of 309) with videos related to

Pageof 31
Sort By:
Global Epidemiology|January 12, 2022
Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, SpainAlbert Roso-Llorach, Xavier Serra-Picamal, Francesc X Cos, et al.
Journal of Virological Methods|April 16, 2014
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencingBirgitte B Simen, Michael S Braverman, Isabella Abbate, et al.
The Journal of Infectious Diseases|June 21, 2019
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment TrialChristina Ekenberg, Man-Hung Tang, Adrian G Zucco, et al.
Plos One|January 13, 2012
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV controlBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
Frontiers in Cellular and Infection Microbiology|July 12, 2023
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world studyJosé Ramón Santos, Maria Casadellà, Marc Noguera-Julian, et al.
Microbiome|April 12, 2022
Gut microbiome signatures linked to HIV-1 reservoir size and viremia controlAlessandra Borgognone, Marc Noguera-Julian, Bruna Oriol, et al.
Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Plos One|July 17, 2010
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeDineke Frentz, Charles A B Boucher, Matthias Assel, et al.
Viruses|July 2, 2021
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated IndividualsBenjamin Trinité, Edwards Pradenas, Silvia Marfil, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Pageof 31

Showing results (241-250 of 309) with videos related to

Sort By:
Pageof 31
Global Epidemiology|January 12, 2022
Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, SpainAlbert Roso-Llorach, Xavier Serra-Picamal, Francesc X Cos, et al.
Journal of Virological Methods|April 16, 2014
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencingBirgitte B Simen, Michael S Braverman, Isabella Abbate, et al.
The Journal of Infectious Diseases|June 21, 2019
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment TrialChristina Ekenberg, Man-Hung Tang, Adrian G Zucco, et al.
Plos One|January 13, 2012
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV controlBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
Frontiers in Cellular and Infection Microbiology|July 12, 2023
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world studyJosé Ramón Santos, Maria Casadellà, Marc Noguera-Julian, et al.
Microbiome|April 12, 2022
Gut microbiome signatures linked to HIV-1 reservoir size and viremia controlAlessandra Borgognone, Marc Noguera-Julian, Bruna Oriol, et al.
Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Plos One|July 17, 2010
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeDineke Frentz, Charles A B Boucher, Matthias Assel, et al.
Viruses|July 2, 2021
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated IndividualsBenjamin Trinité, Edwards Pradenas, Silvia Marfil, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Pageof 31